Eleutheroside B liposomes ameliorate type 2 diabetes mellitus by modulating glucose and lipid metabolism: A metabolomic study
EB‑LIP may improve the bioavailability of EB and exert its antidiabetic effects via multi‑target and multi‑pathway mechanisms. This study supports developing phytochemical-based nanomedicines for complex metabolic diseases.
Authors
- Yuxia Luan (ORCID: https://orcid.org/0000-0002-7480-2642)
- Meiqi Sun (ORCID: https://orcid.org/0000-0003-2546-7021)
- Qiang Chen (ORCID: https://orcid.org/0009-0008-8408-936X)
- Ye Qiu (ORCID: https://orcid.org/0000-0001-8451-8138)
- Yanxu Zhang (ORCID: https://orcid.org/0000-0002-4091-7142)
- Weiqi Wang (ORCID: https://orcid.org/0000-0002-7905-3126)
- Wenyan Chi
- Zhidong Qiu
- Zhu Ming
Institutions
- Changchun University of Chinese Medicine (CN)
Publication Details
- Journal
- Phytomedicine
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1016/j.phymed.2025.157628
- Primary Topic
- Natural Antidiabetic Agents Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00